INTS: Intensity Therapeutics, Inc. Stock

by  •  • Comments Off on INTS: Intensity Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 28.24
Enterprise Value ($M) 25.65
Book Value ($M) 2.92
Book Value / Share 0.19
Price / Book 9.68
NCAV ($M) 1.50
NCAV / Share 0.10
Price / NCAV 18.85

Profitability (mra)
Return on Invested Capital (ROIC) -5.32
Return on Assets (ROA) -1.31
Return on Equity (ROE) -1.67

Liquidity (mrq)
Quick Ratio 1.92
Current Ratio 1.92

Balance Sheet (mrq) ($M)
Current Assets 3.36
Assets 4.78
Liabilities 1.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.59
Net Income -16.27

Cash Flow Statement (mra) ($M)
Cash From Operations -15.22
Cash from Investing 6.35
Cash from Financing 2.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 8.13
12-30 13G Sapient Capital Llc 7.40
06-07 13G LFP Management, LLC 5.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 o TRANSITION REPORT PURSUANT TO SECTI
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,858 34,738 5.35
2025-04-16 1,234 4,237 29.12
2025-04-15 2,334 7,549 30.92
2025-04-14 1,755 5,709 30.74

(click for more detail)

Similar Companies
INM – InMed Pharmaceuticals Inc. INMB – INmune Bio, Inc.
INO – Inovio Pharmaceuticals, Inc. IPA – ImmunoPrecise Antibodies Ltd.
IRD – Opus Genetics, Inc.


Financial data and stock pages provided by
Fintel.io